Skip to main content
Journal of Multimorbidity and Comorbidity logoLink to Journal of Multimorbidity and Comorbidity
. 2026 May 23;16:26335565261455727. doi: 10.1177/26335565261455727

Magnitude of multimorbidity and associated factors among stroke survivors in public hospitals of Ethiopia

Getachew Azeze Eriku 1,✉, Chalachew Mersha 2, Tesfa Kasa 1, Destaw Marie Merawie 1, Ermias Solomon Yalew 1, Mihret Dejen Takele 1
PMCID: PMC13199702  PMID: 42199496

Abstract

Background

Multimorbidity is a growing global challenge, associated with premature death, impaired activities of daily living, reduced capacity for independent living, poor functional outcomes, and lower quality of life. However, there is limited evidence on multimorbidity and their determining factors among stroke survivors in the Ethiopian context. This study aimed to assess the prevalence of multimorbidity and its associated factors among stroke survivors in public hospitals of Amhara Regional State Northwest Ethiopia.

Methods

A multi-center, institution-based cross-sectional study was conducted from June 26 to August 30, 2024. Systematic random sampling was used to select 292 study participants. Data were collected using a structured, interviewer-administered questionnaire and chart review. Bivariable and multivariable logistic regression analyses were performed to identify factors associated with multimorbidity. Variables with a p-value < 0.05 in multivariable analysis were considered statistically significant.

Result

The prevalence of multimorbidity was 72.9%. Hypertension was the most frequently reported comorbidity. Significant factors associated with multimorbidity included age 50 and above (AOR: 2.48, 95% CI: 1.29, 4.74), having no formal education (AOR: 3.72, 95% CI: 1.49, 9.26), secondary education (AOR: 3.76, 95% CI: 1.46, 9.73), use of assistive technology (AOR: 2.60, 95% CI: 1.32, 5.09), duration of hospitalization (AOR:3.08,95%CI:1.37,6.95), and post-stroke disability (AOR: 4.47, 95% CI: 2.23,8.93).

Conclusions

Multimorbidity is highly prevalent. Targeted interventions particular focus on aged population, educational status, assistive technology provision, and post-stroke disability are essential to improve health outcomes.

Keywords: comorbidity, multimorbidity, stroke, disability, stroke survivors

Background

Multimorbidity, defined as the coexistence of two or more chronic conditions, 1 is an increasing global public health problem, particularly in low- and middle-income countries (LMICs), including Ethiopia.2,3 Among people living with chronic diseases, stroke survivors constitute a particularly vulnerable group, as they commonly experience multiple comorbid conditions due to shared risk factors and stroke-related complications. The presence of multimorbidity complicates clinical management, increases treatment burden, and associated with poorer health outcomes and reduced quality of life, largely because of disease-disease and disease-drug interactions.4,5

In Ethiopia, the burden of stroke is high, with the pooled prevalence of ischemic and hemorrhagic stroke reported as 46.42 and 51.40, respectively, 6 while access to comprehensive rehabilitation services remains limited. The coexistence of multiple chronic conditions further worsens morbidity and impedes optimal recovery among stroke survivors. 7 Evidence from high-income countries shows a high magnitude multimorbidity among stroke survivors. Studies from the United kingdom (UK) 8 and Scotland 9 report that 85-94% of stroke survivors have at least one additional comorbid condition, nearly double the prevalence observed in the general population. Hypertension (HTN) is the most common comorbidity, affecting over 60% of stroke survivors and is a major contributor to increased treatment burden, reduced adherence to rehabilitation, and poorer post stroke outcomes.10,11

The relationship between multimorbidity and health outcomes is multi-faceted. Stroke survivors often experience multiple chronic conditions including HTN, diabetes mellitus (DM), heart disease, and mental health disorders. These conditions may coexist before the stroke or develop afterward as secondary complications, both of which affect functional recovery. 12 Post-stroke disability, prolonged hospitalization, dependence on assistive technology can further increase the likelihood of multimorbidity, particularly in settings where healthcare access and continuity of care is limited.13–15

Multimorbidity has been consistently associated with increased healthcare costs, longer hospital stays, higher mortality risks,16,17 and reduced health-related quality of life (HRQOL).18–22 Evidence from Ethiopia shows stroke survivors frequently experience disability and depression, both of which significantly reduce HROQOL and complicates rehabilitation and long-term management. 23 Stroke survivors with multiple chronic conditions often face compounded physical, cognitive, and psychological sequelae that further delay recovery. 24 Globally, post-stroke impairment is common, with up to 75 % of stroke survivors experiencing some level of impairment and 15-30% reporting long-term disability.25,26 Chronic conditions such as DM, musculoskeletal disorder and mental health problems-particularly depression-play significant role in these adverse outcomes.27–30

In resource-restricted settings like Ethiopia, multimorbidity is influenced by a combination of socioeconomic and clinical factors, including age, educational status, socioeconomic condition, duration of hospitalization, use of assistive technologies, and post-stroke disability.25,31,32 Older adults, individuals with lower educational attainment, and those with functional limitations are particularly at risk. 32 Understanding, how these factors interact to influence multimorbidity is therefore essential for developing effective, individualized, and context-specific care strategies. 33

Given the rising burden of stroke and its frequent coexistence with other chronic conditions, 34 understanding the prevalence and associated factors of multimorbidity among stroke survivors is critical. Finding from this study will help inform integrated, patient-centered approaches to stroke care that address both stroke and comorbid conditions, with the potential to improve rehabilitation outcomes and quality of life. Therefore, this study aims to assess prevalence of multimorbidity and its associated factors among stroke survivors attending in public hospitals in the Amhara regional state.

Methods

Study design and period

A multicenter cross-sectional study was conducted from July 1 to August 30, 2024, among stroke survivors attending public hospitals in the Amhara Regional State, Ethiopia.

Study settings

According to the Amhara National Regional Health Bureau, the region has 81 hospitals, 858 health centers, and 3560 health posts. Of the eight comprehensive specialized hospitals providing medical follow-up and physiotherapy services for stroke survivors, five hospitals were randomly selected for this study: University of Gondar Comprehensive Specialized Hospital (UOGCSH), Felege-Hiwot Comprehensive Specialized Hospital (FHCSH), Tibebe Ghion Comprehensive Specialized Hospital (TGCSH), Debre-Markos Comprehensive Specialized Hospital (DMCSH), and Debre-Tabor Comprehensive Specialized Hospitals (DTCSH).

For simplicity, the hospital were labeled A -E (see Table 1). Hospital A is located in Gondar city, approximately 655 km northwest of Addis Ababa. Hospitals B and C located in Bahir Dar, the capital of the Amhara National Regional State, about 486 km from Addis Ababa. Hospital D is found in Debre Markos City, roughly 300 km from Addis Ababa and 250 km from Bahir Dar. Hospital E is located in Debre Tabor city, approximately 100 km from Bahir Dar and about 589 km from Addis Ababa.

Table 1.

Details of hospital, including head count, study sample, and selected sample size in Amhara Regional State, Ethiopia.

Hospital code Name of hospital Head count at hospital Study sample Sample size
A UOGCSH 240 69 68
B FHCSH 210 65 64
C TGCSH 206 64 61
D DMCSH 160 50 46
E DTCSH 190 58 53

Currently, these comprehensive specialized hospitals serve a catchment population of more than 20 million people, including those from neighboring regions.

Study population

The study population consisted of stroke survivors attending medial and physiotherapy outpatient follow-up services at the selected hospitals during the data collection period. Based on hospitals reports, an estimated total of 1,006 stroke survivors attended the medical and physiotherapy outpatient departments during the two-month data collection period.

Inclusion and exclusion criteria

Stroke survivors’ aged 18 years and above, with at least two months since stroke onset, were included. Stroke survivors diagnosed with dementia, severe cognitive impairment, aphasia, or other additional neurological conditions were excluded.

Sample size determination

The sample size was calculated using a single population proportion formula. Since no prior study on this topic has been conducted in Ethiopia, a proportion of 50% was assumed, with a 5% margin of error and a 95% confidence level. A 10 % non-response rate was added to account for incomplete data.

Based on hospitals reports, an estimated total of 1,006 stroke survivors attended the medical and physiotherapy outpatient departments during the two-month data collection period:

The initial sample size was calculated as follows:

n=(Za/2)2*P(1−P)d2=(1.96)2* 0.5(1−0.5)(0.05)2=384.16∼385

Where n=samples, P-prevalence and d-margin of error

Since the total population (N=1006) was less than 10,000, the finite population correction formula was applied.

n′=n1+1N=3851+3851006=278

After adding a 10 % non-response rate, the final sample size was 306 (278+28) participants.

Sampling strategies

A proportional allocation was used to distribute the sample across the selected hospitals. During the study period, 240, 210, 206, 160, and 190 stroke survivors attended the outpatient departments of hospital A, B, C, D, and E, respectively, totaling 1006 stroke survivors. The sampling interval (Kth) was calculated by dividing the total number of stroke survivors by the final sample size (1006/306=3). The first participant in each hospital was randomly selected using a lottery method and, every third eligible participants was recruited systematic random sampling until the required sample size was reached. Accordingly, 68 participants were selected from A, 64 from B, 61 from C, 46 from D, and 53 from E. See Table 1.

Data collection tool and procedures

Data were collected from complementary sources, including interviewer-administered questionnaire developed from various literature sources,8,35–38 medical chart reviews, and standardized assessment tools. The questionnaire included sociodemographic and clinical characteristics of the stroke survivors, and sociodemographic information was collected through direct interviews.

Medical chart review served two purposes 1 : to extract clinical characteristics of stroke, including stroke type, lesion location, duration since stroke onset, duration of hospitalization, and related medical history; and 2 to identify physician-diagnosed chronic conditions such as HTN, DM, kidney diseases, heart conditions, HIV/AIDS and asthma. These conditions were used to construct the outcome variables-multimorbidity-defined as the coexistence of two or more chronic conditions.

Functional and psychological status of stroke survivors were used validate tools. Post-stroke disability was assessed using the 12-item World health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) while the Hospital Anxiety and Depression Scale (HDAS) tools was used assess depressive and anxiety symptoms among stroke survivors. Both the WHODAS 2.039,40 and the HDAS 41 are acceptable, validated and reliable tools for Amharic speakers in Ethiopia.

Definitions of variables

Multimorbidity

The co-existence of two or more physician-diagnosed comorbid conditions in stroke survivors.42,43 A chart review was done to identify physician-diagnosed comorbid conditions.

Depression and anxiety disorder

Post-stroke depression and anxiety are measured by the Hospital Anxiety and Depression Scale (HADS). It has a total score of 0-42 (0-21 for each subscale (depression and anxiety). A score of ≤ 7 on either the depression or anxiety subscale is considered being in the normal range (HADS-D ≥8) HADS-A ≥8. 44

Data quality assurance

The questionnaire was initially prepared in English, then translated into Amharic, the local language, to ensure clarity and culturally appropriateness. The translation was independently done by two physiotherapy lectures who hold master’s degrees and experience in research and clinical practice. Discrepancies were resolved through consensus to maintain conceptual and semantic equivalence with the original English version. The Amharic questionnaire was then pretested on a pilot study of 5% of stroke survivors to assess clarity, comprehension, and applicability, and necessary revisions were made accordingly.

Data were collected by five physiotherapists, with one data collector assigned to each hospital. Prior to data collection, a one-day training was provided by the supervisor, covering the study objectives’, participant approach, informed consent procedures, use of the data collection tool, and data collection procedures. During data collection, continues supervision and daily checks were conducted by the supervisor and principal investigator to ensure completeness, accuracy, consistency, and adherence to the study protocol.

After data collection, completed questionnaires were reviewed for completeness and consistency before data entry to maintain data quality.

Data analysis

The collected data were coded and entered into EPI-data version 4.4.3.1 and then exported to SPSS version 23 for analysis. The normality of continuous variables was assessed using the Shapiro-Wilk test. Variables with a p-value <2.0 in the bivariable logistic regression analysis were considered candidates for the multivariable logistic regression model. Multicollinearity among independent variables was assessed using the variance inflation factor (VIF), with values < 10 indicating the absence of significant multicollinearity. Model fitness was evaluated using the Hosmer-Lemeshow goodness-of-fit test, which indicated an adequate model fit (p-value=0.49).

Descriptive statistics, including means, frequencies, percentages, and tables, were used summarizes the characteristics of the study participants. Binary logistic regression analysis was performed to identify factors associated with multimorbidity among stroke survivors. Crude odds ratios (COR) and adjusted odds ratios (AOR), with 95% confidence intervals (95% CI), were calculated to estimate the strength of associations between the dependent and independent variables. Variables with a p-value <0.05 in the multivariable analysis were considered statistically significant.

Results

A total of 292 stroke survivors participated in this study, with a response rate of 95.4%. The remaining participants were excluded due to incomplete data. The finding includes the sociodemographic characteristics, clinical information, prevalence of multimorbidity, and factors associated with multimorbidity among stroke survivors in public hospitals of the Amhara Regional State, Ethiopia.

Prevalence of multimorbidity among stroke survivors in public hospitals, Ethiopia

The prevalence of multimorbidity is 72.9 % (213) (95 % CI: 68.7%-78.1%).

Sociodemographic characteristics of stroke survivors

A total of 292 stroke survivors participated in this study, with mean age of 56.3±14.2 years and a response rate of 95.4%. More than half of the participants were male. Nearly two-thirds were married and resided in urban areas. About one-third of the participants had no formal education, and over two-thirds reported a monthly income less than ETB 5000. See Table 2.

Table 2.

Sociodemographic characteristics of stroke survivors in public hospitals, Ethiopia, 2024.

Variables Category Frequency (%)
Age 50 and below 121(41.4%)
Above 50 171(58.6)
Sex Male 164(56.2)
Female 128(43.8)
Marital status Married 202 (69.2)
Unmarried 90(20.8)
Residence Urban 192(65.8)
Rural 100(34.3)
Educational level Have no formal education 87(29.8)
Primary education 72(24.7)
Secondary education 52(17.8)
Diploma and above 81(27.7)
Occupation Governmental employee 80(27.4)
Housewife 71(24.3)
Farmer 56 (19.2)
Non-governmental employee 55(18.8)
Retire 30(10.3)
Income <5000 205(70.2)
>5000 87(29.8)

Clinical factors among stroke survivors in public hospitals, Ethiopia

More than half of the study participants experienced an ischemic type of stroke (59.6%), with left side involvement (52.7%). Additionally, 53.8% were dependent on assistive devices for mobility. See Table 3.

Table 3.

Clinical factors among stroke survivors in public hospitals, Ethiopia, 2024.

Variables Categories Frequency (%)
Type of stroke Ischemic 174(59.6)
Hemorrhagic 118(40.4)
Involved side Right side 138(47.3)
Left side 154(52.7)
Usage of AD Yes 157 (53.8)
No 135(46.2)
Duration of hospitalization Short stay (<7 days) 63(21.6)
Moderate (7-14 days) 99 (33.9)
Long (>14 days) 130 (44.5)
Post-stroke disability Yes 144 (49.3)
No 148(50.7)

Factors associated with multimorbidity among stroke survivors in public hospitals, Ethiopia

Age above 50, low educational attainment, usage of assistive devices, prolonged hospitalization, and having a disability were significantly associated with multimorbidity. See Table 4.

Table 4.

Factors associated with multimorbidity among stroke survivors in public hospitals, Ethiopia, 2024.

Variables Categories Multimorbidity COR 95% CI AOR %CI p-value
Yes No
Age 50 and below 70 (57.9) 51(42.1) Ref Ref ​
Above 50 143(83.6) 28(16.3) 3.73(2.16, 6.40) 2.48(1.29,4.74) 0.006
Sex Male 110(67.1) 54(32.9) Ref Ref ​
Female 103(80.5) 25(19.5) 2.02(1.17, 3.45) 1.54(0.77, 3.06) 0.22
Marital status Married 142(70.3) 60(29.7) Ref Ref ​
Unmarried 71(78.9) 19(21.1) 1.58(0.87, 2.84 1.18(0.54, 2.41) 0.64
Education Have no formal education 74(85.1) 13(14.9) 5.28(2.53, 11.00) 3.72(1.49,9.26) 0.005
Primary education 54(75) 18(25) 2.78(1.39,5.54) 1.87(.082,4.22) 0.13
Secondary education 43(82.7) 9(17.3) 4.43(1.91, 10.28) 3.76(1.45, 9.73) 0.006
Diploma and above 42(51.9) 39(48.1) Ref Ref ​
Occupation Govern. Employ 50(62.5) 30(17.5) Ref Ref ​
Housewife 60(84.5) 11(15.5) 3.27(1.49, 7.18) 1.15(0.303, 4.39) 0.83
Farmer 45(80.4) 11(19.6) 2.45(1.10, 5.46) 0.61(0.11, 3.20) 0.55
Non-governmental employee 34(61.8) 21(38.2) 0.97(0.47, 1.97) 0.73(0.29, 1.80) 0.49
Retired 24(80) 6(20) 2.40(.88, 6.54) 1.05(0.28, 3.87) 0.94
Involved side Right side 109(79) 29(21) 1.81(1.06, 3.07) 1.85(0.969, 3.52) 0.06
Left side 104(67.5) 50(32.5) ​ ​ ​
Usage of AD Yes 130(82.8) 27(17.2) 3.02 (1.75, 5.17) 2.60(1.32,5.09) 0.005
No 83(61.5) 52(38.5) ​ ​ ​
Duration of hospitalization in days Short stay (<7 days) 33(52.4) 30(47.6) Ref Ref ​
Moderate (7-14) 72(72.7) 27(27.3) 2.42(1.24, 4.70) 1.69(0.76, 3.77) 0.19
Long (14 and longer) 108(83.1) 22(16.9) 4.46(2.27, 8.75) 3.08(1.37, 6.95) 0.006
Post-stroke disability Yes 128(88.9) 16(11.1) 5.93(3.21,10.95) 4.47(2.23, 8.93) 0.000
No 85(57.4) 63(42.6) Ref Ref ​

Discussion

Our study assessed the prevalence of multimorbidity and its associated factors among stroke survivors in public hospitals in Ethiopia. We found a high prevalence, with nearly three-quarters (72.9%) of participants experiencing two or more comorbid conditions. This aligns from rural Appalachia, USA, where 78% of stroke survivors had three or more comorbid conditions. 38 However, our prevalence was lower than that reported in the UK (85%) 8 and the USA (90%). 35 These differences may reflect variations in life expectancy, healthcare access, and socioeconomic conditions between high- and low-income countries. For instance, the mean age of participants in the USA 35 and UK 8 studies was 78 and 60.9 years, respectively, compared to 56.2 years in our study. Stroke survivors in high-income countries tend to live longer, increasing the likelihood of accumulating chronic conditions. 36 Socioeconomic disparities, limited preventive care, and lower diagnostic capacity in low income-settings may also contribute to the observed differences. 43

Conversely, our prevalence was higher than the 27.9 % reported in a UK population-based study, 37 likely due to difference in study design and study participant characteristics. Population-based studies typically include healthier individuals, whereas our facility-based study included stroke survivors attending medical and physiotherapy follow-up clinics, who are more likely to present with multiple chronic conditions.

In our study, depressive symptoms, and HTN were the most frequently reported comorbidities, accounting for 72.9% and 66.1% of stroke cases, respectively. These findings are consistent with prior Ethiopian studies, which reported prevalence rate of 64.1% 45 and 47% 46 for depressive symptoms and 33.5% for HTN. 45 A similar pattern has been observed globally, with HTN reported in 50.8% 47 and 92.6% 48 of stroke survivors in Nigeria, 54%-84% in the USA(35, 39), and 77 % 49 to 80 % 50 in Sweden and Scotland respectively. This findings underscores the global role of HTN as a leading risk factor for stroke and recurrent cardiovascular events.

Sociodemographic and clinical factors were significantly associated with multimorbidity. Older age (≥50 years), low educational attainment, use of assistive devices, prolonged hospitalization, and post-stroke disability were significant predictors of multimorbidity. Stroke survivors aged ≥ 50 years had 2.48 times higher odds of multimorbidity (AOR: 2.48, 95% CI: 1.29- 4.74), consistent with findings from the UK, which demonstrated a strong association between age and multimorbidity. 8 The accumulation of chronic conditions with aging likely explains this association, as cardiovascular disease remains a leading cause of morbidity and mortality among older stroke survivors. 51

Educational status was another factor significantly associated: stroke survivors with no formal education (AOR: 3.72, 95% CI: 1.49-9.26) or secondary education (AOR: 3.76, 95% CI: 1.45-9.73) were more likely to experience multimorbidity compared to those with a diploma or higher. This finding is supported by studies from the USA, 52 UK, 53 and Denmark. 54 A possible explanation is that lower educational status may reduce health literacy, delay diagnosis, and restrict access to healthcare resources, thereby increasing vulnerability to comorbid conditions.

Among clinical factors, the use of assistive devices was associated with higher odds of multimorbidity (AOR: 2.6, 95% CI: 1.32-5.09), likely reflecting stroke severity and functional limitations. Prolonged hospitalization (>14 days) was also significantly associated (AOR; 3.08, 95% CI 1.37- 6.95) with a higher likelihood of multimorbidity compared to those hospitalized for less than 7 days, consistent with findings from the USA. 35 Prolonged hospitalization may reflect complications, slower recovery, deconditioning, increased dependency, and higher healthcare needs due to comorbid conditions.

Post-stroke disability showed a strong association with multimorbidity (AOR: 4.47, 95% CI, 2.23-8.93). This bidirectional relationship indicates that multimorbidity accelerates functional decline, while post-stroke disability increases vulnerability to additional chronic conditions.55,56 Previous studies have shown that each additional chronic conditions increases the risk of functional impairment by 16%, reduces life expectancy by nearly two years, and raises the need for professional care by 20%.57,58 Similarly, studies in China) 59 and Japan 60 found that multimorbidity was associated with limitations in both activities of daily living (ADL) and instrument activities of daily living (IADL). This finding also supported by a study from USA, which reported that older stroke survivors with multimorbidity experienced greater difficulties with ADLs such as dressing, walking, bathing, toileting, earing and bed mobility. 61

The high prevalence of multimorbidity has important clinical and health-system level implications. Stroke survivors with multiple comorbidities often experience reduced QOL, greater functional limitations and higher risks of recurrent hospitalization. In resource-restricted settings like Ethiopia, this places an additional burden on the healthcare system and emphasizes the need for integrated chronic disease management and post-stroke rehabilitation pathways.

Given that depressive symptoms and HTN are modified risk factors for stroke, strengthening primacy prevention is essential. Community-based screening, lifestyle modification programs promoting physical activity, healthy diet, and smoking cessation, along with adherence to antihypertensive and diabetes treatments, are critical strategies. Integrating preventive and rehabilitative care into primary healthcare systems, supported by public awareness campaigns, may help reduce both initial and recurrent stroke.

Clinically, routine screening for multimorbidity, particularly depression and HTN, should be integrated in to stroke rehabilitation programs. Multidisciplinary care involving neurologists, physiotherapists, and primary care providers is essential. Targeted interventions for high risks groups such as older adults and individuals with disabilities, should focus on improving health literacy, managing comorbidities, and enhancing access to rehabilitation services. Integrating physiotherapy, mental health support, and comorbidity management can help break the disability-multimorbidity cycle.

Strength and limitations

A key strength of this study is that it provides valuable insight into the prevalence and associated factors of multimorbidity among stroke survivors in Ethiopia. These findings offer valuable baseline data to inform clinical practice and guide future research in similar low-resource settings. However, the cross-sectional design limits causal interference between identified factors and multimorbidity. In addition, the study sample may not be fully representative of all stroke survivors, as recruitment was restricted to government hospitals and individuals attending scheduled follow-up visits. This approach may have excluded stroke survivors receiving care in private facilities or those without regular access to follow-up services, potentially introducing selection bias related to healthcare access and socioeconomic status. Moreover, the hospital-based nature of the study may have excluded community-dwelling stroke survivors, which could have led to an underestimation of the true prevalence of multimorbidity. Future longitudinal, population-based studies are warranted to establish temporal relationships and better elucidate the mechanisms underlying the identified determinants.

Conclusion

In conclusion, the high prevalence of multimorbidity among stroke survivors, coupled with its strong association with age, educational attainment, prolonged hospitalization, utilization of assistive devices, and post-stroke disability, highlight the need for integrated, patient-centered care. Addressing the identified predictors through individualized, multidisciplinary interventions can help reduce the burden of multimorbidity and improve the QOL for stroke survivors. Future research should include larger, community-based samples from both public and private facilities to enhance generalizability.

Acknowledgments

Firstly, we would like to express our deepest gratitude to the University of Gondar for funding this work. Our gratitude and appreciation go to the data collectors, study participants, neurologic and physiotherapy OPD staff, and data collectors.

Appendix.

Acronyms and abbreviations

ADLs

activities of daily livings

AOR

adjusted odds ratio

DM

Diabetes Mellitus

DMCSH

Debre Marks comprehensive specialized hospital

DTCSH

Debre Tabor comprehensive specialized hospital

FHCSH

Felege Hiwot comprehensive specialized hospital

HTN

Hypertension

HDAS

Hospital Anxiety and Depression scale

IADLs

instrumental activities of daily livings

OR

Odds Ratio

TGCSH

Tibebe Ghion comprehensive specialized hospital

UOGCSH

University of Gondar Compressive Specialized Hospital

USA

United States of America

UK

united kingdom

WHO

World Health Organization

WHODAS 2.0

World Health Organization Disability Assessment Schedule 2.0

Author note: 1Department of physiotherapy, College of Medicine and Health Science, University of Gondar, Gondar Ethiopia.

2Department of Physiotherapy, University of Gondar Comprehensive Specialized Hospital, University of Gondar, Gondar Ethiopia.

Authors’ contributions: GAE and CM were responsible for designing the study, data acquisition, conceiving the study, dataset tabulation, and data analyses, and supervised the project. TK, MDT, DMM, and ESY participated in the analysis, manuscript writing, and revised the draft. All authors reviewed and approved the final manuscript.

Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was fully resourced and funded by the University of Gondar. The views presented in the article are the authors and not necessarily express the views of the funding organization. University of Gondar did not involve in the design of the study, data collection, analysis, and interpretation.

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

ORCID iD

Getachew Azeze Eriku https://orcid.org/0000-0001-6348-8750

Ethical considerations

Ethical clearance was obtained from the Ethical Review Committee of the School of Medicine College of Medicine and Health Sciences, University of Gondar (Ref No.1558/2024), in accordance with the principles of the declaration of Helsinki. 62

Consent to participate

All participants provided a written informed consent to participate in the study.

Consent for publication

Consent for publication section was to indicate that there is no personal information or photos of participants that would require consent for publication.

Data Availability Statement

All data relevant to our findings are contained within the manuscript. Requests for further details on the dataset and queries concerning data sharing shall be arranged based on a reasonable request to the first and corresponding author (Getachew Azeze Eriku).*

References

  • 1.World Health O . Multimorbidity. WHO; 2016. [Available from: https://iris.who.int/bitstream/handle/10665/252275/9789241511650-eng.pdf [Google Scholar]
  • 2.Basto-Abreu A, Barrientos-Gutierrez T, Wade AN, et al. Multimorbidity matters in low and middle-income countries. J Multimorb Comorb 2022; 12: 26335565221106074. 10.1177/26335565221106074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Eyowas FA, Schneider M, Alemu S, et al. Magnitude, pattern and correlates of multimorbidity among patients attending chronic outpatient medical care in Bahir Dar, northwest Ethiopia: The application of latent class analysis model. PLoS One 2022; 17(4): e0267208. 10.1371/journal.pone.0267208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Valderas JM, Starfield B, Sibbald B, et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009; 7(4): 357–363. 10.1370/afm.983 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gallacher KI, Jani BD, Hanlon P, et al. Multimorbidity in Stroke. Stroke 2019; 50(7): 1919–1926. 10.1161/STROKEAHA.118.020376 [DOI] [PubMed] [Google Scholar]
  • 6.Abate TW, Zeleke B, Genanew A, et al. The burden of stroke and modifiable risk factors in Ethiopia: A systemic review and meta-analysis. PLoS One 2021; 16(11): e0259244. 10.1371/journal.pone.0259244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tsehayneh F, Tafesse A. High Prevalence of Poststroke Depression in Ischemic Stroke Patients in Ethiopia. Neurol Res Int 2020; 2020: 8834299. 10.1155/2020/8834299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gallacher KI, McQueenie R, Nicholl B, et al. Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 UK Biobank participants. Journal of comorbidity 2018; 8(1): 1–8. 10.15256/joc.2018.8.129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gallacher KI, Batty GD, McLean G, et al. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden. BMC Med 2014; 12: 151. 10.1186/s12916-014-0151-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pedersen RA, Petursson H, Hetlevik I. Stroke follow-up in primary care: a Norwegian modelling study on the implications of multimorbidity for guideline adherence. BMC Family Practice 2019; 20(1): 138. 10.1186/s12875-019-1021-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bhagavathula AS, Seid MA, Adane A, et al. Prevalence and Determinants of Multimorbidity, Polypharmacy, and Potentially Inappropriate Medication Use in the Older Outpatients: Findings from EuroAgeism H2020 ESR7 Project in Ethiopia. Pharmaceuticals (Basel) 2021; 14(9): 844. 10.3390/ph14090844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pengpid S, Peltzer K. Prevalence and correlates of multiple non-communicable diseases risk factors among male and female adults in Sudan: results of the first national STEPS survey in 2016. Afr Health Sci 2022; 22(2): 728–735. 10.4314/ahs.v22i2.82 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gebremariam SA, Yang HS. Types, risk profiles, and outcomes of stroke patients in a tertiary teaching hospital in northern Ethiopia. eNeurologicalSci 2016; 3: 41–47. 10.1016/j.ensci.2016.02.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mohammed S, Haidar J, Ayele BA, et al. Post-stroke limitations in daily activities: experience from a tertiary care hospital in Ethiopia. BMC Neurol 2023; 23(1): 364. 10.1186/s12883-023-03419-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Aytenew TM, Kefale D, Birhane BM, et al. Poststroke cognitive impairment among stroke survivors in Sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health 2024; 24(1): 2143. 10.1186/s12889-024-19684-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Menotti A, Mulder I, Nissinen A, et al. Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol 2001; 54(7): 680–686. 10.1016/s0895-4356(00)00368-1 [DOI] [PubMed] [Google Scholar]
  • 17.Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med. 2007; 22(Suppl 3): 391–395. 10.1007/s11606-007-0322-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Fortin M, Lapointe L, Hudon C, et al. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2004; 2: 51. 10.1186/1477-7525-2-51 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ryan A, Wallace E, O'Hara P, et al. Multimorbidity and functional decline in community-dwelling adults: a systematic review. Health Qual Life Outcomes 2015; 13: 168. 10.1186/s12955-015-0355-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bayliss EA, Bayliss MS, Ware JE, Jr, et al. Predicting declines in physical function in persons with multiple chronic medical conditions: what we can learn from the medical problem list. Health Qual Life Outcomes 2004; 2: 47. 10.1186/1477-7525-2-47 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lehnert T, Heider D, Leicht H, et al. Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev 2011; 68(4): 387–420. 10.1177/1077558711399580 [DOI] [PubMed] [Google Scholar]
  • 22.Abebe SM, Abera M, Eriku GA. Health-related quality of life and associated factors among people with disabilities in Northwest Ethiopia. Scientific Reports 2025; 15(1): 33229. 10.1038/s41598-025-18333-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zemed A, Nigussie Chala K, Azeze Eriku G, et al. Health-related quality of life and associated factors among patients with stroke at tertiary level hospitals in Ethiopia. PLoS One 2021; 16(3): e0248481. 10.1371/journal.pone.0248481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chohan SA, Venkatesh PK, How CH. Long-term complications of stroke and secondary prevention: an overview for primary care physicians. Singapore Med J 2019; 60(12): 616–620. 10.11622/smedj.2019158 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Eriku GA, Mersha C, Takele MD, et al. Level of disability and associated factors among stroke survivors in Ethiopia: a multicenter cross-sectional study. BMC Public Health 2026; 26(1): 438. 10.1186/s12889-025-26147-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bettger JP, Zhao X, Bushnell C, et al. The association between socioeconomic status and disability after stroke: findings from the Adherence eValuation After Ischemic stroke Longitudinal (AVAIL) registry. BMC Public Health 2014; 14: 281. 10.1186/1471-2458-14-281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Quiñones AR, Markwardt S, Botoseneanu A. Diabetes-Multimorbidity Combinations and Disability Among Middle-aged and Older Adults. Journal of General Internal Medicine 2019; 34(6): 944–951. 10.1007/s11606-019-04896-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Shi YZ, Xiang YT, Wu SL, et al. The relationship between frontal lobe lesions, course of post-stroke depression, and 1-year prognosis in patients with first-ever ischemic stroke. PLoS One 2014; 9(7): e100456. 10.1371/journal.pone.0100456 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Carvalho-Pinto BP, Faria CD. Health, function and disability in stroke patients in the community. Braz J Phys Ther 2016; 20(4): 355–366. 10.1590/bjpt-rbf.2014.0171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ju YW, Lee JS, Choi Y-A, et al. Causes and Trends of Disabilities in Community-Dwelling Stroke Survivors: A Population-Based Study. Brain Neurorehabil 2022; 15(1): e5. 10.12786/bn.2022.15.e5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Arokiasamy P, Uttamacharya U, Jain K, et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the study on global ageing and adult health (SAGE) reveal? BMC Med 2015; 13: 178. 10.1186/s12916-015-0402-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Folorunsho S, Abdullateef R, Suleiman M, et al. Social determinants of multimorbidity in older adults in sub-saharan Africa: A systematic review. Palliative and Supportive Care 2025; 23: e150. 10.1017/S1478951525100576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Tan MMC, Barbosa MG, Pinho P, et al. Determinants of multimorbidity in low- and middle-income countries: A systematic review of longitudinal studies and discovery of evidence gaps. Obes Rev 2024; 25(2): e13661. 10.1111/obr.13661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.GBD 2021 Stroke Risk Factor Collaborators . Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973–1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Chen W, Li D. Comorbidity and outcomes among hospitalized patients with stroke: a nationwide inpatient analysis. Front Neurol 2023; 14: 1217404. 10.3389/fneur.2023.1217404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.The L. Making more of multimorbidity: an emerging priority. Lancet 2018; 391(10131): 1637. 10.1016/S0140-6736(18)30941-3 [DOI] [PubMed] [Google Scholar]
  • 37.Downer MB, Luengo-Fernandez R, Binney LE, et al. Association of multimorbidity with mortality after stroke stratified by age, severity, etiology, and prior disability. Int J Stroke 2024; 19(3): 348–358. 10.1177/17474930231210397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kitzman PH, Sutton KM, Wolfe M, et al. The Prevalence of Multiple Comorbidities in Stroke Survivors in Rural Appalachia and the Clinical Care Implications. J Stroke Cerebrovasc Dis 2019; 28(11): 104358. 10.1016/j.jstrokecerebrovasdis.2019.104358 [DOI] [PubMed] [Google Scholar]
  • 39.Denu ZA, Yassin MO, Bisetegn TA, et al. The 12 items Amharic version WHODAS-2 showed cultural adaptation and used to measure disability among road traffic trauma victims in Ethiopia. BMC Psychol 2021; 9(1): 1. 10.1186/s40359-020-00492-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Habtamu K, Alem A, Medhin G, et al. Validation of the World Health Organization Disability Assessment Schedule in people with severe mental disorders in rural Ethiopia. Health Qual Life Outcomes 2017; 15(1): 64. 10.1186/s12955-017-0647-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Reda AA. Reliability and validity of the Ethiopian version of the hospital anxiety and depression scale (HADS) in HIV infected patients. PLoS One 2011; 6(1): e16049. 10.1371/journal.pone.0016049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Belayneh AG, Temachu YZ, Messelu MA, et al. Prolonged length of stay and its associated factors at adult emergency department in amhara region comprehensive specialized hospitals, northwest Ethiopia. BMC Emergency Medicine 2023; 23(1): 34. 10.1186/s12873-023-00804-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Skou ST, Mair FS, Fortin M, et al. Multimorbidity. Nat Rev Dis Primers 2022; 8(1): 48. 10.1038/s41572-022-00376-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta psychiatrica scandinavica 1983; 67(6): 361–370. 10.1111/j.1600-0447.1983.tb09716.x [DOI] [PubMed] [Google Scholar]
  • 45.Eticha BL, Yalew ES, Merawie DM, et al. A higher burden of post-stroke depression and anxiety and their predictors among stroke survivors in the Amhara Regional State, Ethiopia, in 2024: a prospective multicenter study. Front Psychiatry 2025; 16: 1545807. 10.3389/fpsyt.2025.1545807 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Gobezie M, Kibret AK, Kassa T, et al. Factors associated with depressive symptoms among stroke survivors in public hospitals of Amhara regional State, Ethiopia: a multicenter cross-sectional study. Sci Rep 2025; 15(1): 33841. 10.1038/s41598-025-03847-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Maduagwu SM, Ezeukwu AO, Saidu IA, et al. Co-morbidities and socio-demographic distribution of stroke survivors referred for physiotherapy in a Nigerian Teaching Hospital: a retrospective study. Nigerian Postgraduate Medical Journal 2012; 19(4): 240–243. [PubMed] [Google Scholar]
  • 48.Ezejimofor MC, Uthman OA, Maduka O, et al. Stroke survivors in Nigeria: A door-to-door prevalence survey from the Niger Delta region. J Neurol Sci 2017; 372: 262–269. 10.1016/j.jns.2016.11.059 [DOI] [PubMed] [Google Scholar]
  • 49.Lin Q, Ye T, Ye P, et al. Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2·5 million participants from multinational screening campaigns. Lancet Glob Health 2022; 10(8): e1141–e1149. 10.1016/S2214-109X(22)00238-8 [DOI] [PubMed] [Google Scholar]
  • 50.Appelros P, Matérne M, Jarl G, et al. Comorbidity in Stroke-Survivors: Prevalence and Associations with Functional Outcomes and Health. J Stroke Cerebrovasc Dis 2021; 30(10): 106000. 10.1016/j.jstrokecerebrovasdis.2021.106000 [DOI] [PubMed] [Google Scholar]
  • 51.Rådholm K. Cardiovascular risk factors in elderly With special emphasis on atrial fibrillation. hypertension and diabetes: Linkopings Universitet (Sweden) 2015.
  • 52.Johnson-Lawrence V, Zajacova A, Sneed R. Education, race/ethnicity, and multimorbidity among adults aged 30-64 in the National Health Interview Survey. SSM Popul Health 2017; 3: 366–372. 10.1016/j.ssmph.2017.03.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.North TL, Harrison S, Bishop DC, et al. Educational inequality in multimorbidity: causality and causal pathways. A mendelian randomisation study in UK Biobank. BMC Public Health 2023; 23(1): 1644. 10.1186/s12889-023-16369-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Schramm S, Møller SP, Tolstrup JS, et al. Effects of individual and parental educational levels on multimorbidity classes: a register-based longitudinal study in a Danish population. BMJ Open 2022; 12(2): e053274. 10.1136/bmjopen-2021-053274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Aubert CE, Kabeto M, Kumar N, et al. Multimorbidity and long-term disability and physical functioning decline in middle-aged and older Americans: an observational study. BMC Geriatr 2022; 22(1): 910. 10.1186/s12877-022-03548-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Pengpid S, Peltzer K, Anantanasuwong D. Bidirectional association between functional disability and multimorbidity among middle-aged and older adults in Thailand. Front Public Health 2022; 10: 1055699. 10.3389/fpubh.2022.1055699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Rizzuto D, Melis RJF, Angleman S, et al. Effect of Chronic Diseases and Multimorbidity on Survival and Functioning in Elderly Adults. J Am Geriatr Soc 2017; 65(5): 1056–1060. 10.1111/jgs.14868 [DOI] [PubMed] [Google Scholar]
  • 58.Davies LE, Mercer SW, Brittain K, et al. The association between multimorbidity and mobility disability-free life expectancy in adults aged 85 years and over: A modelling study in the Newcastle 85+ cohort. PLoS Med 2022; 19(11): e1004130. 10.1371/journal.pmed.1004130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Su P, Ding H, Zhang W, et al. The association of multimorbidity and disability in a community-based sample of elderly aged 80 or older in Shanghai, China. BMC Geriatr 2016; 16(1): 178. 10.1186/s12877-016-0352-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Jiao D, Watanabe K, Sawada Y, et al. Multimorbidity and functional limitation: the role of social relationships. Arch Gerontol Geriatr 2021; 92: 104249. 10.1016/j.archger.2020.104249 [DOI] [PubMed] [Google Scholar]
  • 61.Ruksakulpiwat S, Zhou W, Phianhasin L, et al. Associations between diagnosis with stroke, comorbidities, and activity of daily living among older adults in the United States. Chronic Dis Transl Med 2023; 9(2): 164–176. 10.1002/cdt3.60 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.World Medical Association . Ethical principles for medical research involving human subjects. European journal of emergency medicine: official journal of the European Society for Emergency Medicine 2001; 8(3): 221–223. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data relevant to our findings are contained within the manuscript. Requests for further details on the dataset and queries concerning data sharing shall be arranged based on a reasonable request to the first and corresponding author (Getachew Azeze Eriku).*


Articles from Journal of Multimorbidity and Comorbidity are provided here courtesy of SAGE Publications

RESOURCES